Mental health struggles may play a larger role in approaching HIV prevention than patients realize. How do symptoms of depression and anxiety affect HIV risk behaviors, and how can health care professionals educate patients and increase prevention?
Women living with HIV have a unique set of mental health risks and stressors, but are their needs being met? Healthcare providers should be aware of these 5 ways that women with HIV are experiencing detriments to their mental health.
Men who have sex with men have an increased risk of meningococcal disease, however, this risk is under-ascertained and improved surveillance is needed.
Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.
Alcohol use may be associated with microstructural compromise to frontal white matter in patients infected with HIV who do not have dementia and are undergoing antiretroviral therapy.
In the new subgroup analysis, these results were found to be consistent regardless of baseline regimen.
The approval of Intelence for this patient population was based on an open-label, single arm trial (N=20) which showed that the safety and efficacy of etravirine + an optimized background regimen (ritonavir-boosted protease inhibitor in combination with 1 or 2 NRTIs [N=14] and/or combination with an integrase inhibitor [N=7]) was comparable to that observed in adults.
The FDA has approved Symtuza for the treatment of HIV-1 infection in treatment-naive and in virologically suppressed adults.
Concerns and motivations regarding living donor status in people with HIV should be assessed by physicians and independent living donor advocates.
Investigators used DXA scans to assess the progression to osteopenia and osteoporosis in individuals with HIV.
